Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Opal

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Lung|April 28, 2019
Inter-α-inhibitor Ameliorates Endothelial Inflammation in SepsisVandy P Stober, Yow-Pin Lim, Steven Opal, et al.
Photobiomodulation, Photomedicine, and Laser Surgery|September 20, 2022
Antimicrobial Efficacy of Continuous Low-Irradiance Phototherapy Against Multidrug-Resistant OrganismsPatrick McMullan, Alexander B White, Oluwadara Coker, et al.
Shock (Augusta, Ga.)|December 24, 2005
Preclinical models of shock and sepsis: what can they tell us?John C Marshall, Edwin Deitch, Lyle L Moldawer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 2, 2019
An Integrated Safety Summary of Omadacycline, a Novel Aminomethylcycline AntibioticSteven Opal, Thomas M File, Tom van der Poll, et al.
Critical Care (London, England)|June 8, 2018
Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsisDebasree Banerjee, Sean Monaghan, Runping Zhao, et al.
Shock (Augusta, Ga.)|February 11, 2016
THE EPITHELIUM AS A TARGET IN SEPSISLakhmir S Chawla, Mitchell Fink, Stuart L Goldstein, et al.
Critical Care Medicine|September 23, 2009
Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trialR Phillip Dellinger, John F Tomayko, Derek C Angus, et al.
Critical Care Medicine|June 10, 2003
Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trialDaniel P Schuster, Michael Metzler, Steven Opal, et al.
Intensive Care Medicine|June 15, 2007
Antibiotic management of suspected nosocomial ICU-acquired infection: does prolonged empiric therapy improve outcome?Mary-Anne W Aarts, Christian Brun-Buisson, Deborah J Cook, et al.
Critical Care Medicine|March 19, 2016
Long-Term Quality of Life Among Survivors of Severe Sepsis: Analyses of Two International TrialsSachin Yende, Shamly Austin, Andrew Rhodes, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Lung|April 28, 2019
Inter-α-inhibitor Ameliorates Endothelial Inflammation in SepsisVandy P Stober, Yow-Pin Lim, Steven Opal, et al.
Photobiomodulation, Photomedicine, and Laser Surgery|September 20, 2022
Antimicrobial Efficacy of Continuous Low-Irradiance Phototherapy Against Multidrug-Resistant OrganismsPatrick McMullan, Alexander B White, Oluwadara Coker, et al.
Shock (Augusta, Ga.)|December 24, 2005
Preclinical models of shock and sepsis: what can they tell us?John C Marshall, Edwin Deitch, Lyle L Moldawer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 2, 2019
An Integrated Safety Summary of Omadacycline, a Novel Aminomethylcycline AntibioticSteven Opal, Thomas M File, Tom van der Poll, et al.
Critical Care (London, England)|June 8, 2018
Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsisDebasree Banerjee, Sean Monaghan, Runping Zhao, et al.
Shock (Augusta, Ga.)|February 11, 2016
THE EPITHELIUM AS A TARGET IN SEPSISLakhmir S Chawla, Mitchell Fink, Stuart L Goldstein, et al.
Critical Care Medicine|September 23, 2009
Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trialR Phillip Dellinger, John F Tomayko, Derek C Angus, et al.
Critical Care Medicine|June 10, 2003
Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trialDaniel P Schuster, Michael Metzler, Steven Opal, et al.
Intensive Care Medicine|June 15, 2007
Antibiotic management of suspected nosocomial ICU-acquired infection: does prolonged empiric therapy improve outcome?Mary-Anne W Aarts, Christian Brun-Buisson, Deborah J Cook, et al.
Critical Care Medicine|March 19, 2016
Long-Term Quality of Life Among Survivors of Severe Sepsis: Analyses of Two International TrialsSachin Yende, Shamly Austin, Andrew Rhodes, et al.
Pageof 4